Website & contact details
- Website
Amphista Therapeutics Limited
- Incorporated
- 20 December 2017 (8 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Bart Dzikowski
- Accounts type
- Group
- Region
- East of England
- Address
- The Cori Building Granta ParkGreat AbingtonCambridgeCB21 6GQ
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 20 December 2026
- Last conf. stmt
- 6 December 2025
Charges
- Total
- 2
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 1
Officers 7 active
Officer details are public data from the Companies House register.
Director · Appointed 6 March 2026
Irish,American
Born July 1973 (53)
Dzikowski, Bart
Director · Appointed 17 April 2023
Canadian
Born March 1976 (50)
Director · Appointed 9 December 2022
Luxembourger
Born September 1982 (44)
Director · Appointed 16 May 2022
British
Born February 1982 (44)
Brumm, Joshua
Director · Appointed 17 September 2021
American
Born December 1977 (48)
Luzi, Stefan Emanuel
Director · Appointed 12 March 2021
Swiss
Born August 1983 (43)
Rooswinkel, Rogier Wouter, Dr
Director · Appointed 12 March 2021
Dutch
Born August 1983 (43)
Officer history (7 former)
6 March 2026
6 March 2026
Resigned Mattessich, Antony as Director
2 September 2024
Appointed Mattessich, Antony as Director
30 September 2023
Resigned Thompson, Nicola, Dr as Director
17 April 2023
Appointed Dzikowski, Bart as Director
17 April 2023
9 December 2022
16 May 2022
16 May 2022
17 September 2021
Appointed Brumm, Joshua as Director
14 September 2021
Resigned Jindal, Satish, Dr as Director
12 March 2021
Appointed Luzi, Stefan Emanuel as Director
12 March 2021
12 March 2021
Resigned Ciulli, Alessio, Dr as Director
12 March 2021
Appointed Rooswinkel, Rogier Wouter, Dr as Director
23 March 2020
Appointed Jindal, Satish, Dr as Director
8 June 2019
Appointed Thompson, Nicola, Dr as Director
24 January 2019
Resigned Rajkomar, Iyona, Dr as Director
20 December 2017
Appointed Rajkomar, Iyona, Dr as Director
20 December 2017
Appointed Ciulli, Alessio, Dr as Director
20 December 2017
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (5)
12 December 2022
Ceased Advent Life Sciences LLP — Owns 25–50% of shares
28 June 2019
Ceased Advent Life Sciences Fund II LP — Has significant influence or control
28 June 2019
Ceased Alessio Ciulli — Owns 25–50% of shares
27 February 2018
Ceased Advent Life Sciences LLP — Owns 25–50% of shares
20 December 2017
Ceased Advent Life Sciences Fund II LP — Owns 25–50% of shares
Financials
Latest accounts, made up to 31 December 2025, aren't available as data. See them on Companies House
Filings 138
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 November 2026 | Statement of capital following an allotment of shares | |||
| 6 October 2026 | Statement of capital following an allotment of shares | |||
| 24 August 2026 | Memorandum and Articles of Association | |||
| 24 August 2026 | Resolutions | |||
| 22 July 2026 | Statement of capital following an allotment of shares |
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →